RituximabCOVID-19 infection: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1959卷 / 1期

关键词：

D O I：

10.1007/s40278-023-40748-4

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：576 / 576

相关论文

共 50 条

[41] RituximabCOVID-19 pneumonia
Reactions Weekly, 2024, 2017 (1) : 439 - 439
[42] Covid-19-vaccine/rituximabCOVID-19 infection and lack of efficacy caused by drug interactions: case report
Reactions Weekly, 2021, 1879 (1) : 114 - 114
[43] Azathioprine/leflunomide/rituximabCOVID-19: 3 case reports
Reactions Weekly, 2023, 1971 (1) : 52 - 52
[44] Ciclosporin/everolimus/rituximabCOVID-19, Epstein-Barr virus infection and COVID-19 reinfection: case report
Reactions Weekly, 2021, 1885 (1) : 147 - 147
[45] Prednisolone/rituximabCOVID-19 and SARS-CoV-2 pneumonia: case report
Reactions Weekly, 2021, 1879 (1) : 318 - 318
[46] Azathioprine/rituximabCOVID-19 reinfection: 2 case reports
Reactions Weekly, 2025, 2053 (1) : 66 - 66
[47] Methotrexate/prednisone/rituximabCOVID-19 pneumonia: 3 case reports
Reactions Weekly, 2021, 1872 (1) : 307 - 307
[48] Methotrexate/prednisolone/rituximabCOVID-19 pneumonia: 2 case reports
Reactions Weekly, 2021, 1856 (1) : 267 - 267
[49] COVID-19-vaccines/prednisolone/rituximabCOVID-19 pneumonia and lack of efficacy: case report
Reactions Weekly, 2022, 1925 (1) : 190 - 190
[50] Fingolimod/rituximabCOVID-19 and reduced humoral immunity: 3 case reports
Reactions Weekly, 2023, 1968 (1) : 143 - 143

← 1 2 3 4 5 →